Sulfacetamide/sulfur
(Redirected from Plexion)
Combination of | |
---|---|
Sulfacetamide | Sulfonamide antibacterial |
Sulfur (pharmacy) | Keratolytic |
Clinical data | |
AHFS/Drugs.com | Multum Consumer Information |
License data | |
Routes of administration | Topical |
Legal status | |
Legal status |
|
(verify) |
The drug combination sulfacetamide/sulfur is a topical acne medication[1] manufactured by Medicis under the trade name Plexion and also available under other trade names such as Clenia, Prascion, and Avar. It combines sodium sulfacetamide, a sulfonamide antibiotic, and sulfur, a keratolytic agent.[2] It is available in four formulations: as a cleansing cloth, cleanser, topical suspension, and as a facial mask. The sulfacetamide inhibits the growth of the bacterium Cutibacterium acnes that is associated with acne, while sulfur facilitates the removal of dead skin cells to prevent clogged pores.[3]
References
- ^ Del Rosso JQ (January 2004). "Evaluating the role of topical therapies in the management of rosacea: focus on combination sodium sulfacetamide and sulfur formulations". Cutis. 73 (1 Suppl): 29–33. PMID 14959943.
- ^ "PLEXION (R) (sodium sulfacetamide 10% and sulfur 5%)". Medicis Inc. Retrieved 2008-12-02.
- ^ "PLEXION Prescribing information" (PDF). Medicis. Retrieved 2008-12-02.
Categories:
- Articles with short description
- Short description matches Wikidata
- Chemical articles without CAS registry number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs missing an ATC code
- Drugs that are a combination of chemicals
- Anti-acne preparations
- Combination drugs
- All stub articles
- Dermatologic drug stubs